Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia (2020)
- Authors:
- Autor USP: COSTA, FABRICIO DA SILVA - FMRP
- Unidade: FMRP
- DOI: 10.1002/uog.22070
- Subjects: BIOMARCADORES; PRÉ-ECLÂMPSIA; DIAGNÓSTICO PRECOCE; OBSTETRÍCIA
- Keywords: Biomarker; GDF-15; Growth-differentiation factor-15; Prediction; Pre-eclampsia
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Ultrasound in Obstetrics & Gynecology
- ISSN: 0960-7692
- Volume/Número/Paginação/Ano: v. 56, n. 6, p. 879-884, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
WERTASCHNIGG, D. et al. Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia. Ultrasound in Obstetrics & Gynecology, v. 56, n. 6, p. 879-884, 2020Tradução . . Disponível em: https://doi.org/10.1002/uog.22070. Acesso em: 29 dez. 2025. -
APA
Wertaschnigg, D., Rolnik, D. L., Nie, G., Teoh, S. S. Y., Syngelaki, A., Costa, F. da S., & Nicolaides, K. H. (2020). Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia. Ultrasound in Obstetrics & Gynecology, 56( 6), 879-884. doi:10.1002/uog.22070 -
NLM
Wertaschnigg D, Rolnik DL, Nie G, Teoh SSY, Syngelaki A, Costa F da S, Nicolaides KH. Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia [Internet]. Ultrasound in Obstetrics & Gynecology. 2020 ; 56( 6): 879-884.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1002/uog.22070 -
Vancouver
Wertaschnigg D, Rolnik DL, Nie G, Teoh SSY, Syngelaki A, Costa F da S, Nicolaides KH. Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia [Internet]. Ultrasound in Obstetrics & Gynecology. 2020 ; 56( 6): 879-884.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1002/uog.22070 - A randomised controlled trial to assess the feasibility of utilising virtual reality to facilitate analgesia during external cephalic version
- Challenging the definition of hypertension in pregnancy: a retrospective cohort study
- Diagnostic accuracy of transvaginal ultrasound and magnetic resonance imaging for adenomyosis: systematic review and meta-analysis and review of sonographic diagnostic criteria
- Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia
- The importance of ultrasound preceding cell‐free DNA screening for fetal chromosomal abnormalities
- Ultrasound appearances of the acrania‐anencephaly sequence at 10 to 14 weeks’ gestation
- ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in context of COVID‐19
- Assessing peristalsis at the endometrial–myometrial junctional zone: a reproducible ultrasound technique?
- Population-based analysis of atypical chromosomal abnormalities according to nuchal translucency measurement: an individual record-linkage study of 81,244 women
- The effect of preexisting medical comorbidities on the preeclamptic phenotype: a retrospective cohort study
Informações sobre o DOI: 10.1002/uog.22070 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003155452.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
